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Background: We developed a single-color multitarget flow cytometry (SM-FC) assay, a sin-
gle-tube assay with graded mean fluorescence intensities (MFIs). We evaluated the repeat-
ability of SM-FC, and its correlation with multicolor flow cytometry (MFC), to assess its ap-
plication as a routine FC assay. 
Methods: We selected CD19, CD3, CD4, and CD8 as antigen targets to analyze a lympho-
cyte subset. MFIs were graded by adjusting monoclonal antibody (mAb) volumes to detect 
several cell populations. Dimly labeled mAb was prepared by decreasing mAb volume and 
the optimum diluted volume was determined by serial dilution. SM-FC repeatability was an-
alyzed 10 times in 2 normal controls. The correlation between SM-FC and MFC was evalu-
ated in 20 normal and 23 patient samples.
Results: CV values (0.8-5.0% and 1.3-4.1% in samples 1 and 2, respectively) acquired by 
SM-FC with CD3-fluorescein α-isothyocyanate (FITC)dim+CD4-FITCbright and with CD19-
FITCdim+CD3-FITCbright showed good repeatability, comparable to that acquired by MFC 
(1.6-3.7% and 1.0-4.8% in samples 1 and 2, respectively). Excellent correlation was ob-
served between the 2 methods in the 20 normal samples (B cells, T cells, non-Thelper cells, 
and Thelper cells; r
2=0.87, 0.97, 0.97, and 0.98, respectively; P<0.05). There were also lin-
ear relationships between SM-FC with CD19-FITCdim+CD3-FITCbright and CD8-PEdim+ CD4-
PEbright, and MFC, in the 23 patient samples (B cells, T cells, Tcytotoxic cells, and Thelper cells; 
r
2≥0.98, 0.99, 0.99, and 0.99, respectively; P<0.05).
Conclusions: The multicolor, single-tube SM-FC technique is a potential alternative tool for 
identifying a lymphocyte subset. 
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INTRODUCTION
Multicolor flow cytometry (MFC) is widely used in health research 
and treatment for a variety of tasks, such as providing the counts 
of helper-T lymphocytes needed to monitor the course and treat-
ment of human immunodeficiency virus (HIV) infection [1-3], 
diagnosing and monitoring leukemia and lymphoma patients [4, 
5], and evaluating peripheral blood hematopoietic stem cell 
grafts [6] and a variety of other diseases [7]. The technology is 
also used to cross-match organs for transplantation [8], and in 
research involving stem cells, apoptosis [9], phagocytosis [10], 
and a wide range of cellular properties including phenotype [11], 
cytokine expression [12], and cell-cycle status [13]. 
  MFC can enumerate mature T, B, and natural killer (NK) cell 
populations, as well as CD4+ and CD8+ T-cell subsets, using 6 
monoclonal antibodies (mAbs), including CD3, CD4, CD8, CD19, 
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CD16, and CD56, in lymphocyte subset analyses [14-17]. Although 
some clinical laboratories routinely use a single-tube assay with 
lyse-no-wash methodology, which reduces inter-laboratory vari-
ability, a single-tube assay requires complex analysis with a mul-
tiple gating strategy [17-20]. The use of complex instruments 
with multicolor analysis, in which every fluorochrome has to be 
accurately compensated for, especially in a lyse-no-wash tech-
nique, can be problematic for an inexperienced operator [18]. 
  With the goal of alleviating these difficulties, we have devel-
oped single-color multitarget flow cytometry (SM-FC), which cir-
cumvents the costly and labor-intensive procedures of manual 
preparation. The process is almost the same as MFC, except for 
the use of mAbs labeled with different mean fluorescence inten-
sities (MFIs) of the same fluorochrome for detecting more than 
two cell populations, as a single-tube assay. We attempted to an-
alyze a lymphocyte subset using this technique with graded MFIs 
by adjusting mAb volumes to detect several cell populations.
  The aim of this study was to estimate the repeatability of SM-
FC, evaluate the correlation between SM-FC and MFC, and as-
sess the potential of the new technique as a routine flow cytom-
etry (FC) approach. We selected CD19, CD3, CD4, and CD8 as 
antigen targets to demonstrate whether SM-FC is routinely ap-
plicable, because these antigens are expressed in a certain lym-
phocyte subset. Subset results obtained using SM-FC and MFC 
were compared in 23 patient samples.
METHODS
1. Subjects
To evaluate the repeatability of SM-FC and the correlation be-
tween SM-FC and MFC, we used 20 blood samples, obtained 
from adults who had visited our hospital for routine medical 
health check-ups. All individuals had displayed normal blood 
test results. Another 23 blood samples that had been obtained 
from patients for lymphocyte analysis were used to assess the 
potential of the novel technique as a routine FC approach. These 
patients had been variously diagnosed with aplastic anemia (N= 
4), myelodysplatic syndrome (N=3), AML (N=6), ALL (N=3), 
HIV infection (N=6), and infectious mononucleosis (N=1), but 
not initially with lymphoid malignancies such as ALL, CLL, and 
lymphoma. Sixteen patients with hematologic malignancies had 
a successful post-hematopoietic stem cell transplantation status 
for at least 6 months. Total white blood cell (WBC) count ranged 
from 1.33 to 14.54×10
9/L (median, 5.40×10
9/L). Lymphocyte 
count ranged from 0.49 to 6.12×10
9/L (median, 2.03×10
9/L). All 
blood samples were collected in vacutainer tubes coated with 
K2-EDTA (Becton-Dickinson, Franklin Lakes, NJ, USA) and were 
processed within 4 hr of blood collection.
2. Antibodies and flow cytometry for SM-FC
Six mAbs were used to evaluate the repeatability of SM-FC and 
the correlation between SM-FC and MFC. The mAbs were fluo-
rescein α-isothyocyanate (FITC)-conjugated CD4, CD3, and 
CD19; phycoerythrin (PE)-conjugated CD8 and CD4; and peri-
dinin chlorophyll protein complex (PerCP)-conjugated CD45 (BD 
Biosciences, San Jose, CA, USA). MFIs were graded by adjust-
ing mAb volumes for detecting several cell populations (i.e., 
multitarget). Dimly labeled mAbs were prepared by decreasing 
mAb volume and the optimal diluted volume was determined 
using serial mAb dilutions. As a result, CD3 and CD19 FITC (0.1 
and 0.5 µL/test, respectively) and CD8 PE (0.1 μL/test) yielded 
weakly positive cell populations in SM-FC. The mAb cocktails 
used in lymphocyte subset analysis are listed in Table 1. To 
compare with MFC, Multitest 6-color TBNK reagent (BD Biosci-
ences), which contains 6 Abs, was used to identify and enumer-
ate T, B, and NK lymphocyte subsets. A single-tube assay with 
the lyse-wash method was performed on 50 μL volumes of 
whole peripheral blood. A 6-color FACSCanto II flow cytometer 
(BD Biosciences) was used in accordance with the manufac-
turer’s recommendation. Data were collected by adjusting the 
Fourier shell correlation (FSC) threshold to exclude platelets and 
debris. List mode data of 10,000 cells was collected according 
to predefined FSC threshold settings. Data analyses were con-
ducted using the FACSDiva program (BD Biosciences).
3. Validation of SM-FC
The repeatability of SM-FC was analyzed 10 times in 2 normal 
controls. The correlation between SM-FC and MFC was evalu-
Table 1. Monoclonal antibody cocktails used for lymphocyte subset 
analysis
Antibody 
combination
Fluorochrome (volume/test)
FITCdim FITCbright PEdim PEbright PerCP
CD3+CD4/-/CD45* CD3
(0.1 μL)
CD4
(5 μL)
CD45
(5 μL)
CD19+CD3/-/CD45*
† CD19
(0.5 μL)
CD3
(5 μL)
CD45
(5 μL)
-/CD8+CD4/CD45
† CD8
(0.1 μL)
CD4
(5 μL)
CD45
(5 μL)
*used for a repeatability of SM-FC and a correlation between SM-FC and 
MFC; 
†used to assess the potential use of SM-FC as a routine FC.
Abbreviations: FITC, fluorescein α-isothyocyanate; PE, phycoerythrin; Per-
CP, peridinin chlorophyll protein complex.Park J, et al.
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ated in 20 normal samples. SM-FC with CD3-FITCdim+CD4-
FITCbright was performed to detect dimly fluorescent non-Thelper 
cells and brightly fluorescent Thelper cells (Th cells). SM-FC with 
CD19-FITCdim+CD3-FITCbright was also achieved to detect weakly 
fluorescent B cells and strongly fluorescent T cells, respectively. 
To assess the potential of this method as a routine FC approach, 
SM-FC with CD19-FITCdim+CD3-FITCbright and CD8-PEdim+CD4-
PEbright was performed to separate dimly fluorescent B cells, dimly 
fluorescent Tcytotoxic cells (Tc cells), and brightly fluorescent Th cells 
in 23 patient samples. 
4. Statistical analysis
The correlation between cell populations obtained by SM-FC and 
MFC was assessed using the Pearson correlation coefficient and 
linear regression analysis. All statistical differences were consid-
ered significant if P<0.05. All statistical analyses were performed 
using MedCalc 12.0 software (MedCalc, Mariakerke, Belgium).
RESULTS
1.     Repeatability of SM-FC with CD3-FITCdim+CD4-FITCbright 
and with CD19-FITCdim+CD3-FITCbright
Negative, dimly fluorescent, and brightly fluorescent cell popu-
lations were clearly distinguished by SM-FC. SM-FC with CD3-
FITCdim+CD4-FITCbright showed negative cells, dimly fluorescent 
non-Th cells, and brightly fluorescent Th cells. SM-FC with CD19-
FITCdim+CD3-FITCbright presented negative cells, weakly fluores-
cent B cells, and strongly fluorescent T cells. The contours of 
the 3 peaks were sufficiently distinguishable and these markers 
could be readily set in each histogram (Fig. 1). Ten analyses in 
2 normal controls revealed good repeatability based on the CV 
values (0.8-5.0% in sample 1; 1.3-4.1% in sample 2) acquired 
by SM-FC, comparable to those acquired by MFC (1.6-3.7% in 
sample 1; 1.0-4.8% in sample 2). The CVs of Th cells and non-Th 
cells obtained by SM-FC and MFC were lower than those of B 
cells (Table 2). 
2.     Correlation between SM-FC with CD3-FITCdim+CD4-
FITCbright and with CD19-FITCdim+CD3-FITCbright, and MFC
There was excellent correlation between SM-FC and MFC (P< 
0.05) in the 20 normal samples tested. Median differences be-
tween the 2 methods were <2%. SM-FC showed similar results 
to those of MFC, and agreed well with those obtained by MFC 
(Table 3).
3.     Potential use of SM-FC with CD19-FITCdim+CD3-FITCbright 
and CD8-PEdim+CD4-PEbright as a routine FC approach
SM-FC adequately separated the lymphocyte population into 4 
subpopulations (negative, dimly fluorescent B cells, dimly fluo-
rescent Tc cells, and brightly fluorescent Th cells (Fig. 2). A linear 
relationship was evident between SM-FC and MFC in the 23 pa-
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Fig. 1. Representative dot plots and histograms of single-color mul-
titarget flow cytometry with CD19-FITCdim+CD3-FITCbright and with 
CD3-FITCdim+CD4-FITCbright. (A) B cells (CD19-FITCdim, brown) and 
T cells (CD3-FITCbright, green). (B) Non-Thelper cells (CD3-FITCdim, pink) 
and Thelper cells (CD3-FITCdim+CD4-FTTCbright, blue). 
Abbreviations: SM-FC, single-color multitarget flow cytometry; PerCP, peri-
dinin chlorophyll protein complex; FITC, fluorescein α-isothyocyanate.
Table 2. Repeatability of single-color multitarget flow cytometry com-
pared to multicolor flow cytometry in 2 normal controls in 10 rounds 
of analysis
Cell population
SM-FC MFC
Mean±SD (%) CV (%) Mean±SD (%) CV (%)
Sample 1
B cell 19.5±1.0 5.0 19.2±0.7 3.6
T cell 64.8±0.5 0.8 63.9±1.0 1.6
non-Thelper cell 23.1±0.9 4.0 24.8±0.9 3.7
Thelper cell 42.7±0.9 2.0 40.5±1.1 2.8
Sample 2        
B cell 11.0±0.5 4.1 10.9±0.5 4.8
T cell 75.3±1.0 1.3 75.3±0.7 1.0
non-Thelper cell 32.4±0.8 2.5 32.2±1.0 3.2
Thelper cell 43.1±0.8 1.8 43.2±1.0 2.3
Abbreviations: SM-FC, single-color multitarget flow cytometry; MFC, multi-
color flow cytometry.Park J, et al.
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tient samples tested (P<0.05); the median difference between 
the 2 methods was <2% (Table 3). 
DISCUSSION
The recent availability of MFC has allowed the absolute enumer-
ation of the lymphocyte subpopulation in a single tube, including 
B lymphocytes or NK cells, at reduced cost and with shorter as-
say times [18-20]. Determination of lymphocyte subpopulations 
is very important in many kinds of immunological [20] and he-
matological disorders [21]. WBC differentiation based on FC rec-
ognition of cells has become a routine test [22-25]. However, 
since one fluorochrome is responsible for detecting only one ex-
pressed antigen, the resulting dot plot will only depict negative or 
positive cell populations in MFC. Because the number of avail-
able fluorochromes may be limited in a single tube, the resolu-
tion of MFC may be insufficient for the analysis of a large num-
ber of different cell populations in a single-tube assay format. To 
overcome the limited number of mAbs that can be used in a 
multicolor, single-tube technique, a sequential gating method 
has been attempted [17-20]. Although this approach permits 
enumeration of the lymphocyte subpopulation, the gating strat-
egy is complex [17-20]. The separation of more than 2 cell popu-
lations using a single fluorochrome in the multicolor single-tube 
technique format exponentially increases the number of possible 
differential cell populations that can be enumerated. 
  The present results demonstrate the favorable repeatability of 
SM-FC and its correlation with MFC. Lymphocyte subsets includ-
ing B cells, Th cells, and Tc cells were successfully verified using 
SM-FC with CD19-FITCdim+CD3-FITCbright and CD8-PEdim+CD4-
PEbright in one dot plot, indicating the potential of SM-FC as a 
routine FC approach. Lymphocyte subpopulations were exclu-
sively determined by antigenic expression; every included lym-
phocyte was positive for one or more markers and negative for 
others. 
  The most important contribution of SM-FC is that more anti-
gen expression profiles can be obtained using multiple mAbs 
conjugated with the same fluorochromes at different intensities 
in a multicolor single-tube assay format. This approach is less 
sensitive to systematic error or bias because it allows for a larger 
lymphocyte window. This single-tube method approach pro-
duces the most complete determination of possible phenotypes, 
improving clinical interpretation and diagnosis. SM-FC also elim-
inates the need to control tube-to-tube population variability 
(quality control) with duplicate reagents, and excludes tube-to-
tube window anomalies. Other practical advantages include de-
creased use of reagents and test tubes, which reduce labor-re-
Table 3. Correlation of single-color multitarget flow cytometry compared to multicolor flow cytometry in 20 normal and 23 patient samples
Sample Cell population
SM-FC (%) MFC (%) Median 
difference (%)
r
2
Median Range Median Range
Normal (N=20) B cell 12.1 7.6-21.6 12.0 7.4-19.0 1.1 0.87
T cell 65.1 53.4-81.8 66.8 52.2-81.7 1.1 0.97
non-Thelper cell 28.3 13.3-43.2 29.8 13.8-45.2 1.6 0.97
Thelper cell 36.3 18.7-54.9 34.9 18.1-52.9 1.3 0.98
Patient (N=23) B cell 10.5 0.2-21.1 9.6 0.2-20.9 0.9 0.98
T cell 71.1 51.1-97.1 72.3 49.3-96.4 0.9 0.99
Tcytotoxic cell 44.2 15.6-76.6 41.9 14.9-76.9 1.3 0.99
Thelper cell 22.0 4.5-43.3 19.9 3.9-41.7 1.5 0.99
Abbreviations: SM-FC, single-color multitarget flow cytometry; MFC, multicolor flow cytometry; r
2, the square of the Pearson correlation coefficient.
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plex; PE, phycoerythrin; FITC, fluorescein α-isothyocyanate.Park J, et al.
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lated costs. However, the routine use of diluted preparations of 
mAbs should be avoided, since subsaturation of a cell surface 
antigen could cause underexpression.
  This novel technique has several limitations. First, most malig-
nant cells such as leukemic blasts or lymphoma cells could pres-
ent variable MFIs or aberrant expression due to their biological 
abnormalities [26]. The expression level of a particular target anti-
gen may vary depending on the loss or gain of typical or aberrant 
antigen expression in hematological malignancies. This new 
method may be more useful to analyze cells that constantly ex-
press target surface antigens, for example, the lymphocyte sub-
set in non-lymphoid malignancies, rather than to immunopheno-
type hematological malignancies. Secondly, some surface anti-
gens, such as CD45, express different MFIs according to the type 
of normal leukocytes present [27]. Therefore, it may not be suit-
able to use mAbs that express various MFIs according to cell type 
in SM-FC. Finally, we have to carefully select the combination of 
dimly and brightly labeled mAbs in SM-FC, since it is not possible 
to distinguish a cell population stained with only brightly labeled 
mAbs from a population stained with dimly as well as brightly la-
beled mAbs using the same fluorochrome. It is better to combine 
mAbs like CD3 and CD19, which are not expressed in the same 
cell population, using the same fluorochrome with different inten-
sities. Antigen coexpression may lead to overlap between dimly 
and brightly labeled mAbs, and cell populations would not be 
clearly distinguishable, leading to inaccurate results. 
  In conclusion, SM-FC not only displays acceptable repeatabil-
ity and correlation in normal samples, but also has potential as 
a routine FC technique. Because there are some difficulties to 
apply to all clinical areas, this method should be applied to ana-
lyze cell populations that present constant levels of antigens in 
non-hematological malignancies or other diseases that do not 
influence the level of antigen expression. In spite of several cur-
rent limitations, SM-FC could be a potential alternative tool, as a 
multicolor, single-tube technique, for the routine clinical labora-
tory detection of a lymphocyte subset.
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